Health Care Fraud Chief Michael Loucks: A Talk With Medicare Drug Focus
Assistant U.S. Attorney Michael Loucks is the chief of the Health Care Fraud Unit at the Boston U.S. Attorney's Office. The Boston office led the cases against TAP Pharmaceuticals, Warner-Lambert and Serono Labs. In an Aug. 10 interview, Loucks discusses potential vulnerabilities for manufacturers and PDPs with the Medicare drug benefit, and describes fact patterns likely to attract prosecutors' attention.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth